McKnight's March 25, 2024
The Centers for Medicare & Medicaid Services disclosed last week it will provide coverage for the popular weight loss drug Wegovy for patients at high risk for cardiovascular disease and stroke.
NBC News and other news organizations reported Thursday that the agency announced Medicare Part D plans will now cover Wegovy when it is prescribed for the prevention of heart attacks, strokes and other serious cardiovascular conditions. Medicaid also will be required to cover the drug to reduce heart disease risk.
Medicare had previously been barred from paying for weight loss medication, but the change will allow for the prescribing of Wegovy for seniors who are overweight and have a history of heart disease, NBC News reported. However, the agency...
Today's Sponsors
Today's Sponsor